SELLAS Life Sciences Group, Inc.
SLS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001390478
No open-market purchases or sales by SELLAS Life Sciences Group, Inc. insiders were filed in the last 90 days; 193 institutions reported holding it in 13F filings for Q2 2026, worth $1.08B in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in SELLAS Life Sciences Group, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −2 vs. Q3 2024
- Shares held
- 6.22M
- +809.7K (+15.0%) vs. Q3 2024
- Total value
- $6.47M
- −$290.5K (−4.3%) vs. Q3 2024
- New holders
- 6
- 10 more added
- Sold out
- 8
- 5 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 193 | $1.08B |
| Q1 2026 | 160 | $228.4M |
| Q4 2025 | 112 | $133.7M |
| Q3 2025 | 94 | $53.1M |
| Q2 2025 | 79 | $58.7M |
| Q1 2025 | 45 | $15.5M |
| Q4 2024 | 31 | $6.47M |
| Q3 2024 | 33 | $6.77M |
| Q2 2024 | 30 | $4.86M |
| Q1 2024 | 30 | $7.82M |
| Q4 2023 | 31 | $3.74M |
| Q3 2023 | 28 | $4.54M |
| Q2 2023 | 25 | $4.91M |
| Q1 2023 | 22 | $4.28M |
| Q4 2022 | 29 | $4.46M |
| Q3 2022 | 28 | $4.42M |
| Q2 2022 | 26 | $6.64M |
| Q1 2022 | 26 | $11.3M |
| Q4 2021 | 27 | $10.1M |
| Q3 2021 | 30 | $17.1M |
| Q2 2021 | 29 | $21.3M |
| Q1 2021 | 31 | $13.3M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding SELLAS Life Sciences Group, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 2,292,857 | $2.38M | 0.00% | 00.0% | Unchanged |
| Anson Funds Management LP | 1,192,266 | $1.24M | 0.15% | +398,431+50.2% | Added |
| Geode Capital Management, LLC | 733,546 | $763.2K | 0.00% | +128,355+21.2% | Added |
| Citadel Advisors LLC | 485,317 | $504.7K | 0.00% | +437,998+925.6% | Added |
| BlackRock, Inc. | 444,208 | $462.0K | 0.00% | +12,590+2.9% | Added |
| Opus Capital Group, LLC | 238,500 | $248.0K | 0.03% | +12,400+5.5% | Added |
| State Street Corp | 227,729 | $236.8K | 0.00% | +53,200+30.5% | Added |
| Northern Trust Corp | 134,721 | $140.1K | 0.00% | +33,878+33.6% | Added |
| UBS Group AG | 127,821 | $132.9K | 0.00% | +127,821 | New |
| XTX Topco Ltd | 53,426 | $55.6K | 0.00% | −9,359−14.9% | Reduced |
| LPL Financial LLC | 51,894 | $54.0K | 0.00% | 00.0% | Unchanged |
| Mariner, LLC | 50,609 | $52.6K | 0.00% | +3,180+6.7% | Added |
| Virtu Financial LLC | 41,155 | $43.0K | 0.00% | −38,086−48.1% | Reduced |
| Independent Financial Group, LLC | 23,250 | $24.2K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 16,238 | $16.9K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 15,778 | $16.4K | 0.00% | −1,657−9.5% | Reduced |
| Goldman Sachs Group Inc | 15,683 | $16.3K | 0.00% | +15,683 | New |
| Commonwealth Equity Services, LLC | 12,054 | $13.0K | 0.00% | −3,500−22.5% | Reduced |
| Jane Street Group, LLC | 12,304 | $12.8K | 0.00% | +12,304 | New |
| Equitable Holdings, Inc. | 12,060 | $12.5K | 0.00% | 00.0% | Unchanged |
| Prosperity Financial Group, Inc. | 11,500 | $12.0K | 0.01% | +11,500 | New |
| Nemes Rush Group LLC | 10,000 | $10.4K | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 5,464 | $5.68K | 0.00% | +5,464 | New |
| Tower Research Capital LLC (TRC) | 5,305 | $5.52K | 0.00% | +1,596+43.0% | Added |
| R Squared Ltd | 2,197 | $2.29K | 0.00% | +2,197 | New |
| Advisor Group Holdings, Inc. | 1,660 | $1.73K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 572 | $595 | 0.00% | +46+8.7% | Added |
| Jones Financial Companies LLLP | 374 | $389 | 0.00% | 00.0% | Unchanged |
| Parkside Financial Bank & Trust | 2 | $3 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 1 | $1 | 0.00% | −186−99.5% | Reduced |
| Royal Bank of Canada | 200 | $0 | 0.00% | 00.0% | Unchanged |
| Diametric Capital, LP | 0 | $0 | 0.00% | −160,194−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −92,937−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −58,338−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −46,335−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −16,591−100.0% | Sold out |
| Calton & Associates, Inc. | 0 | $0 | 0.00% | −14,000−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −5,789−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |